152 related articles for article (PubMed ID: 38034848)
1. Mendelian Randomization Analysis reveals Inverse Genetic Risks between Skin Cancers and Vitiligo.
Rashid S; Molotkov I; Klebanov N; Shaughnessy M; Daly MJ; Artomov M; Tsao H
JID Innov; 2023 Nov; 3(6):100217. PubMed ID: 38034848
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?
Roberts MR; Asgari MM; Toland AE
Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599
[TBL] [Abstract][Full Text] [Related]
3. Cancer risks in patients with vitiligo: a Mendelian randomization study.
Wen Y; Wu X; Peng H; Li C; Jiang Y; Liang H; Zhong R; Liu J; He J; Liang W
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1933-1940. PubMed ID: 32462299
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants for smoking behaviour and risk of skin cancer.
Dusingize JC; Law MH; Seviiri M; Olsen CM; Pandeya N; Landi MT; Iles MM; Neale RE; Ong JS; MacGregor S; Whiteman DC
Sci Rep; 2023 Oct; 13(1):16873. PubMed ID: 37803080
[TBL] [Abstract][Full Text] [Related]
5. Variants of the melanocortin-1 receptor: do they matter clinically?
Haddadeen C; Lai C; Cho SY; Healy E
Exp Dermatol; 2015 Jan; 24(1):5-9. PubMed ID: 25219681
[TBL] [Abstract][Full Text] [Related]
6. Risk of Melanoma and Nonmelanoma Skin Cancer in People with Vitiligo: United Kingdom Population-Based Cohort Study.
Ferguson J; Eleftheriadou V; Nesnas J
J Invest Dermatol; 2023 Nov; 143(11):2204-2210. PubMed ID: 37146674
[TBL] [Abstract][Full Text] [Related]
7. Integrative Analysis of Omics Data Reveals Regulatory Network of
Cai M; Yuan T; Huang H; Gui L; Zhang L; Meng Z; Wu W; Sheng Y; Zhang X
Front Genet; 2021; 12():634553. PubMed ID: 33679896
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.
Nan H; Kraft P; Hunter DJ; Han J
Int J Cancer; 2009 Aug; 125(4):909-17. PubMed ID: 19384953
[TBL] [Abstract][Full Text] [Related]
9. Circulating Vitamin D Levels and Risk of Vitiligo: Evidence From Meta-Analysis and Two-Sample Mendelian Randomization.
Song J; Liu K; Chen W; Liu B; Yang H; Lv L; Sun X; Mao Y; Ye D
Front Nutr; 2021; 8():782270. PubMed ID: 35004812
[No Abstract] [Full Text] [Related]
10. The causal relationship between gut microbiota and inflammatory dermatoses: a Mendelian randomization study.
Mao R; Yu Q; Li J
Front Immunol; 2023; 14():1231848. PubMed ID: 37828993
[TBL] [Abstract][Full Text] [Related]
11. Association of atopic dermatitis with autoimmune diseases: A bidirectional and multivariable two-sample mendelian randomization study.
Zhou W; Cai J; Li Z; Lin Y
Front Immunol; 2023; 14():1132719. PubMed ID: 37063839
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Relationship Between Leukocyte Telomere Length and Cancer Risk/Mortality in UK Biobank and TCGA Datasets With the Genetic Risk Score and Mendelian Randomization Approaches.
Gao Y; Wei Y; Zhou X; Huang S; Zhao H; Zeng P
Front Genet; 2020; 11():583106. PubMed ID: 33193711
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo.
Jin Y; Birlea SA; Fain PR; Ferrara TM; Ben S; Riccardi SL; Cole JB; Gowan K; Holland PJ; Bennett DC; Luiten RM; Wolkerstorfer A; van der Veen JP; Hartmann A; Eichner S; Schuler G; van Geel N; Lambert J; Kemp EH; Gawkrodger DJ; Weetman AP; Taïeb A; Jouary T; Ezzedine K; Wallace MR; McCormack WT; Picardo M; Leone G; Overbeck A; Silverberg NB; Spritz RA
Nat Genet; 2012 May; 44(6):676-80. PubMed ID: 22561518
[TBL] [Abstract][Full Text] [Related]
14. Genetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and Loci.
Shen C; Gao J; Sheng Y; Dou J; Zhou F; Zheng X; Ko R; Tang X; Zhu C; Yin X; Sun L; Cui Y; Zhang X
Front Genet; 2016; 7():3. PubMed ID: 26870082
[TBL] [Abstract][Full Text] [Related]
15. Skin Phototype and Disease: A Comprehensive Genetic Approach to Pigmentary Traits Pleiotropy Using PRS in the GCAT Cohort.
Farré X; Blay N; Cortés B; Carreras A; Iraola-Guzmán S; de Cid R
Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672889
[TBL] [Abstract][Full Text] [Related]
16. Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients.
Rodrigues M
Dermatol Clin; 2017 Apr; 35(2):129-134. PubMed ID: 28317522
[TBL] [Abstract][Full Text] [Related]
17. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo.
Paradisi A; Tabolli S; Didona B; Sobrino L; Russo N; Abeni D
J Am Acad Dermatol; 2014 Dec; 71(6):1110-6. PubMed ID: 25242557
[TBL] [Abstract][Full Text] [Related]
18. Reduced risk of skin cancer and internal malignancies in vitiligo patients: a retrospective population-based cohort study in Taiwan.
Weng YC; Ho HJ; Chang YL; Chang YT; Wu CY; Chen YJ
Sci Rep; 2021 Oct; 11(1):20195. PubMed ID: 34642421
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the melanocortin-1 receptor (MC1R) and agouti signaling protein (ASIP) genes in Korean vitiligo patients.
Na GY; Lee KH; Kim MK; Lee SJ; Kim DW; Kim JC
Pigment Cell Res; 2003 Aug; 16(4):383-7. PubMed ID: 12859622
[TBL] [Abstract][Full Text] [Related]
20. Genetically predicted levels of folate, vitamin B
Yang H; Song J; Li A; Lv L; Sun X; Mao Y; Ye D
Front Immunol; 2023; 14():1139799. PubMed ID: 36969181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
